SEC fundamentals
VITASPRING BIOMEDICAL CO. LTD. (VSBC)
as filed in 10-Q FY2026, period ended Jul 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jul 31, 2026, VITASPRING BIOMEDICAL CO. LTD. reported revenue of $0, net income of -$155,817, and total assets of $14,822. Every figure below is taken directly from VITASPRING BIOMEDICAL CO. LTD.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2017–FY2026 · as reported
- FY2017 revenue
- $0
- FY2026 revenue
- $0
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2026 | $0 | -$415,368 |
| FY2025 | $0 | -$774,922 |
| FY2024 | $0 | -$1.1M |
| FY2023 | $0 | -$4.2M |
| FY2022 | $5.6M | $909,560 |
| FY2021 | $248,200 | $425,382 |
| FY2020 | $15,140 | $6,919 |
| FY2019 | $17,180 | -$22,396 |
| FY2018 | $16,230 | -$6,374 |
| FY2017 | $0 | -$45 |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 10-Q | Sep 17, 2026 | on EDGAR ↗ |
| NT 10-Q | Sep 15, 2026 | on EDGAR ↗ |
| 8-K | Sep 10, 2026 | on EDGAR ↗ |
| 10-Q | Jun 17, 2026 | on EDGAR ↗ |
| 10-Q | Jun 17, 2026 | on EDGAR ↗ |
| 10-Q | Jun 17, 2026 | on EDGAR ↗ |
| 10-K | Jun 17, 2026 | on EDGAR ↗ |
| 10-Q | Jun 15, 2026 | on EDGAR ↗ |
| 10-K | Jun 8, 2026 | on EDGAR ↗ |
| 10-Q | May 6, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jul 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jul 31, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jul 31, 2026
| EPS (diluted) | $0.00 | Earnings | source ↗ |
| EPS (basic) | — | — | source ↗ |
| Shares Outstanding | 207.0M | Entity | source ↗ |
| Cash from Operations | $5,200 | Net | source ↗ |
| Cash from Financing | $0 | Net | source ↗ |
| Cash from Investing | — | — | source ↗ |
Restatement history
Point-in-time11 of 203 annual fact-keys were materially restated between filings: what VITASPRING BIOMEDICAL CO. LTD. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches VSBC’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VSBC
MCP tool:
get_sec_fundamentals ticker=VSBC - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VSBC/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=VSBC as_of=YYYY-MM-DD - Quarter-end prices derived from SEC filings, with their sources and splits
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/prices/VSBC/history?frequency=quarter
MCP tool:
get_sec_price_history ticker=VSBC frequency=quarter - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VSBC/history
MCP tool:
get_fundamentals_history ticker=VSBC - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/VSBC
MCP tool:
get_financial_health ticker=VSBC
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.